LAMEA Retinal Imaging Devices Market By Type (Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography)) By End Use (Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use) By Country, Industry Analysis and Forecast, 2019 - 2025
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the LAMEA Retinal Imaging Devices Market
Market Report Description
The Latin America, Middle East and Africa Retinal Imaging Devices Market would witness market growth of 7.5% CAGR during the forecast period (2019-2025). Increased awareness and training programs in the field of ophthalmology provide a boost to the adoption of advanced and sophisticated imaging devices. The OCT segment is expected to grow at the fastest growth rate during the forecast period. This acceleration is associated with the effectiveness and precision of the diagnosis. The OCT system helps to understand the pathogenesis of the disease, contributing to the development of personalized therapies. In addition, advances in communication technology, including fiber optics & cloud storage facilities, along with the expansion of OCT applications in clinical studies, are expected to drive segment growth in the coming years.
According to the World Health Organization, the levels of unaddressed near vision impairment in western, eastern and central sub-Saharan Africa are estimated to surpass 80 percent in terms of near vision. Cataract prevalence and trachomatous trichiasis among women are higher, especially in low-and middle-income countries. Innovative technologies are evolving to test visual acuity, quickly and cheaply correct the refractive error, capture retinal images with portable devices, train cataract surgeons using simulators, capitalize on mHealth, and remotely access ophthalmic details.
Fluorescein Angiography is also expected to show considerable progress during the forecast period. The main application of this modality is the diagnosis of macular degeneration and diabetic retinopathy. The prevalence of diabetic retinopathy and increased demand for early detection solutions are likely to promote the growth of the segment.
Based on Type, the market is segmented into Fundus Camera, Fluorescein Angiography and OCT (Optical Coherence Tomography). Based on End Use, the market is segmented into Hospitals, Ophthalmic Centers, ASCs (Ambulatory Surgery Centers) and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Topcon Corporation, Carl Zeiss AG, Olympus Corporation, Robert Bosch GmbH (Bosch Healthcare), Revenio Group Oyj (CenterVue SpA), Nikon Corporation (Optos PLC), Optomed PLC, Epipole Ltd., Nidek Co., Ltd., and Eyenuk, Inc.
Scope of the Retinal Imaging Devices Market Analysis
- Fundus Camera
- Fluorescein Angiography
- OCT (Optical Coherence Tomography)
By End Use
- Ophthalmic Centers
- ASCs (Ambulatory Surgery Centers)
- Other End Use
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Topcon Corporation
- Carl Zeiss AG
- Olympus Corporation
- Robert Bosch GmbH (Bosch Healthcare)
- Revenio Group Oyj (CenterVue SpA)
- Nikon Corporation (Optos PLC)
- Optomed PLC
- Epipole Ltd.
- Nidek Co., Ltd.
- Eyenuk, Inc
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free